Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
BONESUPPORT HOLDING AB ( (SE:BONEX) ) has shared an update.
BONESUPPORT Holding AB will publish its interim report for the first quarter of 2026 on April 22 at 08:00 CEST and follow up with a conference call and online presentation at 10:00 CEST. The results session, led by CEO Torbjörn Sköld and CFO Håkan Johansson and held in English, will allow stakeholders to ask questions via webcast or teleconference, underscoring the company’s effort to maintain transparent communication with investors and the market around its financial performance and strategic progress.
More about BONESUPPORT HOLDING AB
BONESUPPORT Holding AB, listed on Nasdaq Stockholm under the ticker BONEX, operates in the orthobiologics sector, developing and commercializing injectable bio-ceramic bone graft substitutes. Its CERAMENT-based products are designed to remodel into the patient’s own bone and can elute drugs, with the company targeting improved clinical and health-economic outcomes in the treatment of bone injuries. Headquartered in Lund, Sweden, BONESUPPORT reported net sales of SEK 1,175 million in 2025 and is running several clinical studies to strengthen evidence for its technology platform.
Average Trading Volume: 332,131
Technical Sentiment Signal: Buy
Current Market Cap: SEK15.54B
Learn more about BONEX stock on TipRanks’ Stock Analysis page.